Contract Development/Manufacturing Organization (CDMO)

The best choice in CDMO for IVD materials and expertise

Zymetas is best known for its research and development of unique markers across a wide range of disorders including Bacterial Vaginosis (BV), Sexually Transmitted Infections (STIs), Emerging Infectious Diseases (EIDs), Neglected Tropical Diseases (NTDs) and Zoonoses.

Our reputation is built on, not only bringing these markers to the market, but also on developing the clinical evidence in routine use over many years. We have partnerships with many of the world’s largest diagnostic companies to deliver crucial raw materials, product development support and manufacturing on which they depend.

The complete CDMO package

Our competence to supply IVD raw materials and develop novel biomarkers, uniquely positions us in the market as the primary content provider to the diagnostics industry. Zymetas offers diagnostic companies a comprehensive range of products and services from “raw material to finished product”:

Critical raw materials manufacturing

We develop and manufacture core materials and antibodies and have the capacity to supply them at scale anywhere in the world. High quality is guaranteed by state-of-the-art GMP manufacturing facilities, ISO certifications, a mature quality system, and the application of the same materials across multiple technologies..

Customization and co-development

We develop core materials ourselves and have the expertise to customize solutions to the technology needs of our customers. Our experts are ready to help and work together with CDMOs to develop the markers of tomorrow, customized to their platform. We have a proven track record of developing assays and providing a level of regulatory consultation that ensures marketability.

Production on a global scale

Beyond our assay development competence, we also mass produce the relevant product at global market scale. Our GMP manufacturing sites strategically placed around the world guarantee consistency of both quality, supply and on-time delivery wherever needed.  

Auditing

Our global footprint allows us to meet both the internal quality standards of our partners and the requirements of national or regional regulatory bodies with regard to manufacturing and product quality standards. 

Continuous development

On our own and in partnership with global researchers, we continue to develop new markers which will add value to the clinical management of patients. Access to these new markers helps our partners refresh and expand their product portfolios more rapidly and efficiently. We develop long term partnerships based on the shared desire to meet the world’s ever-changing clinical needs.

More information about our CDMO capabilities:

• Primers and Probes Design
• Oligos and Genes Supply
• Contract Manufacturing
• Product Development
• Regulatory Services
• Clinical Services